Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

Completed · Phase 3

Conditions studied: Hot Flashes, Prostate Cancer

In brief

RATIONALE: Cyproterone acetate may be effective treatment for hot flashes following surgical or chemical castration for prostate cancer. It is not yet known which regimen of cyproterone acetate is more effective for hot flashes. PURPOSE: Randomized phase III trial to determine the effectiveness of cyproterone acetate in treating patients who have hot flashes following surgical or chemical castration for prostate cancer.

Key facts

Study ID

NCT00005623

Run by

Barr Laboratories

Starts

1999-12-01

Expected to finish

2004-01-01

Last updated by the study team

2013-03-26

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Barr Laboratories, Incorporated — Pomona, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.